Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez
B
B
Department of Renal Diseases and Clinical Pathology, Hospital Universitario Dr José Eleuterio González, Monterrey, México.
Flores
A
A
Pérez
F
F
Córdoba
C
C
García
L
L
Vázquez
G
G
D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000188:drug therapy*; D004906:Erythrocyte Count; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D012156:Reticulocytes / Q000187:drug effects
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D005293:Ferritins; D007501:Iron